所有图片(1)

主要文件

COO原产地证书/COA分析证书

查看所有文档

24368C

EX-CELL^® Advanced CHO Feed 1 (不含葡萄糖)

Name: EX-CELL<SUP>®</SUP> Advanced CHO Feed 1 (不含葡萄糖)
Brand: SIGMA

别名:

EX-CELL^® Advanced CHO Feed 1

登录查看公司和协议定价

所有图片(1)

About This Item

UNSPSC代码:

12352200

NACRES:

NA.71

推荐产品

Slide 1 of 10

1 of 10

SAFC

14366C

EX-CELL^® Advanced CHO Fed-batch培养基

SAFC

24366C

EX-CELL^® Advanced CHO Fed-batch培养基

SAFC

14365C

EX-CELL^® CD CHO Fusion

SAFC

24367C

EX-CELL^® Advanced CHO Feed 1 (含葡萄糖)

SAFC

24365C

EX-CELL^® CD CHO Fusion

SAFC

C6366

EX-CELL^® CHO克隆培养基

SAFC

14361C

EX-CELL^® CD CHO 无血清培养基，用于 CHO 细胞，成分明确

SAFC

104132

Cellvento^® ModiFeed Prime COMP

SAFC

14390C

Cellvento^® 4CHO-C克隆培养基

SAFC

1.03796

Cellvento^® 4Feed COMP

产品线

EX-CELL^®

质量水平

500

表单

dry powder

技术

cell culture | mammalian: suitable (suspension)

运输

ambient

储存温度

2-8°C

正在寻找类似产品? 访问产品对比指南

一般描述

EX-CELL^® Advanced CHO Feed 1 (不含葡萄糖)化学成分明确且不含有动物来源成分。该补料用于分批补料平台，可与EX-CELL^® Advanced CHO 分批补料培养基（14366C或24366C）一起使用。来自SAFC的最新平台经过特别开发设计，用于维持分批补料培养物中各种中国仓鼠卵巢（CHO）细胞的生长和生产，同时可灵活调节蛋白质的质量属性。这种实时分批补料平台采用多变量分析策略开发，以确定配方成分影响关键过程和产品属性（如滴度、褶皱膨胀（fold expansion）、受体表达、和T糖基化）的相关性。该平台不含次黄嘌呤和胸苷、 L-谷氨酰胺、酚红或2-巯基乙醇（2-ME）。

联系

提交EX-CELL Advanced CHO Fed-batch申请表以与SAFC代表取得联系。

数量

按照每升培养基34.1克粉末配制。

法律信息

EX-CELL is a registered trademark of Merck KGaA, Darmstadt, Germany

14366C

EX-CELL^® Advanced CHO Fed-batch培养基, liquid

象形图

GHS05,GHS07

警示用语：

Danger

危险声明

H315,H317,H318

预防措施声明

P261 - P264 - P272 - P280 - P302 + P352 - P305 + P351 + P338

危险分类

Eye Dam. 1 - Skin Irrit. 2 - Skin Sens. 1

储存分类代码

11 - Combustible Solids

WGK

WGK 3

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Slide 1 of 5

1 of 5

SAFC

14361C

EX-CELL^® CD CHO 无血清培养基，用于 CHO 细胞，成分明确

SAFC

59920C

EX-CELL^®止泡剂

SAFC

1.02578

Cellvento^® Feed-220

Sigma-Aldrich

G8769

D -(+)-葡萄糖溶液

SAFC

14700C

EX-CELL^® CD Hydrolysate Fusion 化学限定水解物

Attenuated glutamine synthetase as a selection marker in CHO cells to efficiently isolate highly productive stable cells for the production of antibodies and other biologics.

Pao-Chun Lin et al.

mAbs, 11(5), 965-976 (2019-05-03)

Chinese hamster ovary (CHO) cells are the biopharmaceutical industry's primary means of manufacturing therapeutic proteins, including monoclonal antibodies. The major challenge in cell line development for the production of recombinant biopharmaceuticals lies in generating and isolating rare high-producing stable clones

商品

One-step Feed Optimization for Upstream Cell Culture Processes

Optimizing feed for upstream cell culture improves monoclonal antibody production, but requires balancing outcomes for both viable cell density and productivity.

Improving Fed-batch Yields in Upstream Bioprocessing

Our step-by-step guide to optimizing media and feed combinations for upstream bioprocessing.

EX-CELL^® Advanced™ CHO Fed-Batch System – Bioprocessing Technology Institute, Singapore Case Study

In this study, nine commercially available, chemically defined media and feed combinations from different vendors were assessed for producing monoclonal antibody in Chinese hamster ovary (CHO) cells.

Low-Impurity Iron Sources: Case Studies in EX-CELL^® Advanced Medium

Discover how low-impurity iron sources improve reliability and performance in recombinant protein production with EX-CELL^® Advanced medium.

查看所有结果

主要文件